Post-therapy change in prostate-specific antigen levels as a clinical trial endpoint in hormone-refractory prostatic cancer: a trial with 10-ethyl-deaza-aminopterin.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples